Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors.
about
Effects of growth hormone and pioglitazone in viscerally obese adults with impaired glucose tolerance: a factorial clinical trialObesity: Current and potential pharmacotherapeutics and targets.The role of ghrelin in GH secretion and GH disorders.Effects of exercise training intensity on nocturnal growth hormone secretion in obese adults with the metabolic syndrome.Effects of continuous versus intermittent exercise, obesity, and gender on growth hormone secretion.Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?The effect of caloric restriction interventions on growth hormone secretion in nonobese men and women.The Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity.The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors.GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90Normal sweat secretion despite impaired growth hormone-insulin-like growth factor-I axis in obese subjectsEffect of oral glucose administration on rebound growth hormone release in normal and obese women: the role of adiposity, insulin sensitivity and ghrelin.Multipathway modulation of exercise and glucose stress effects upon GH secretion in healthy men.Growth Hormone Dynamics in Healthy Adults Are Related to Age and Sex and Strongly Dependent on Body Mass IndexIdiopathic adult growth hormone deficiency.Androgens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion.Hormonal responses to acute exercise, training and overtraining. A review with emphasis on the horse.Anthropometry, CT, and DXA as predictors of GH deficiency in premenopausal women: ROC curve analysisImpaired IGF1-GH axis and new therapeutic options in Alström Syndrome patients: a case series.Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone.The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS.Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism.Hyperphagia in male melanocortin 4 receptor deficient mice promotes growth independently of growth hormone.A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophy.The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects.
P2860
Q28469197-44A9592D-1A02-4DB1-BEB8-9E32F9537285Q30243992-91DEEDF2-0613-483C-9AC2-F63968AB9319Q30410009-96FDDA95-3786-46A4-93AA-F8C835B31681Q30435986-0F4A5F12-0868-4A57-A9D4-F2F8DC791830Q30437776-8B980640-3832-47DA-905E-FB855CC1653DQ33569163-4CEEF800-FD24-4C23-94A4-75A8DA8FC9FAQ33596295-FE6C8F47-741B-40CB-8759-6CEEE7C816E8Q33602919-5F0E9A34-F578-4FE6-B1DA-BE8528146B76Q33633368-C075202B-C454-40EB-9A61-CC4DE3A1E25EQ35103887-0BCD3F98-2B63-48F9-8883-A475928E255EQ35147135-6E2D143F-18A2-4196-8826-B44D6AB5AEF1Q35188165-8EBE8340-B005-4299-8164-47BD1ED82B8FQ35987593-017BAA03-377E-458A-B75B-5FF3801C4199Q36515626-381EA491-A506-4F9F-BBE7-B1F6EBAA768FQ36885877-566B9DBE-A5BE-4501-AE9E-D0F937D1C673Q36964832-00086777-CF77-43F3-845F-FA9A8D2F656BQ36985687-DB741604-41CA-4D4A-8200-A18DB2958335Q37101164-27D9733F-6A80-4157-95B9-F1C87C1EA116Q37111966-8DEF5728-5E1C-4D25-8A1A-FB0121C4FE17Q37396676-A4852A94-C79F-4582-9487-E118C636AA93Q38097351-5CAC9AB9-E335-4CD3-9062-F4E31E3B5902Q38105267-911EE2BF-28E3-4131-8C86-D29A09FCCD5CQ40521614-7E20FEE3-5E76-4022-B3D7-BA91C2B1D782Q42510897-9D3EC3EA-D9E4-449D-A73A-066FF79F4228Q48054858-2DB5C4F4-382D-461D-AD35-F625D8682A94Q51492504-080FA3BE-96F5-421E-B918-46513B225849Q51766789-FE9E0D5F-9A78-4056-8C2F-D90E6C91715A
P2860
Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Abdominal visceral fat and fas ...... d other physiological factors.
@ast
Abdominal visceral fat and fas ...... d other physiological factors.
@en
type
label
Abdominal visceral fat and fas ...... d other physiological factors.
@ast
Abdominal visceral fat and fas ...... d other physiological factors.
@en
prefLabel
Abdominal visceral fat and fas ...... d other physiological factors.
@ast
Abdominal visceral fat and fas ...... d other physiological factors.
@en
P2093
P356
P1476
Abdominal visceral fat and fas ...... d other physiological factors.
@en
P2093
Bouchard C
Hartman ML
Thorner MO
Weltman JY
P304
P356
10.1210/JC.86.8.3845
P407
P577
2001-08-01T00:00:00Z